Next Article in Journal
Correction: Ziemssen et al. Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC). Vaccines 2023, 11, 1374
Previous Article in Journal
Correction: Murphy, H.; Ly, H. Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines. Vaccines 2022, 10, 1668
Previous Article in Special Issue
Anti-SARS-CoV-2 Vaccination and PIMS-TS—Friends or Foe? Case Reports and Literature Review
 
 
Article

Article Versions Notes

Vaccines 2024, 12(8), 910; https://doi.org/10.3390/vaccines12080910
Action Date Notes Link
article xml file uploaded 12 August 2024 11:47 CEST Original file -
article xml uploaded. 12 August 2024 11:47 CEST Update https://www.mdpi.com/2076-393X/12/8/910/xml
article pdf uploaded. 12 August 2024 11:47 CEST Version of Record https://www.mdpi.com/2076-393X/12/8/910/pdf
article supplementary file uploaded. 12 August 2024 11:47 CEST - https://www.mdpi.com/2076-393X/12/8/910#supplementary
article html file updated 12 August 2024 11:49 CEST Original file https://www.mdpi.com/2076-393X/12/8/910/html
Back to TopTop